Search Results

This short report describes the number, percent, and characteristics of specialty mental health treatment facilities in the United States that offered supported employment, an evidence-based practice for individuals with serious mental illness to gain employment.

This CBHSQ short report uses data from the 2011 Treatment Episode Data Set – Discharges (TEDS-D) and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to provide a portrait of treatment discharges among those referred to treatment by the criminal justice system, hereafter referred to as criminal justice...

This report looks at SAMHSA Block Grants that serve as a safety net for individuals without health insurance or other resources who seek specialty substance use treatment and prevention services. Under the Affordable Care Act, some of the treatment options that were covered by the SAMHSA Block Grants are likely...

This report looks at costs for substance use disorder treatment reported in the 2010 National Ambulatory Medical Care Survey. These data include costs for prescriptions for medications and behavioral treatment used to treat alcohol use disorders and opioid use disorders made in office visits to general and family practice physicians...

This is a Treatment Episode Data Set (TEDS) short report showing the age of substance use initiation among treatment admissions aged 18 to 30 in 2011. The Treatment Episode Data Set (TEDS) is a national data system of annual admissions to substance abuse treatment facilities. TEDS received treatment admission records...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving buprenorphine between 2005 and 2011. Buprenorphine is used to treat dependence on heroin and narcotic pain medications. The report also shows buprenorphine-related visits broken out by non-medical use, adverse reactions and seeking detoxification...

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.